drug · vaccine component
respiratory syncytial virus vaccine
Phase 2updated 5mo agoby $MRNA Moderna, Inc.🔗 ChEMBL
Phase 2community read0 votes
Vaccine component drug with a maximum clinical stage of Approval, with an approval for respiratory syncytial virus infection.
targets
Fusion glycoprotein F0
all catalysts(0)
nothing on the calendar yet
Trials studying respiratory syncytial virus vaccine
News(1)
- GSK lays off 650 staffers amid closure of German vaccine manufacturing siteGSK is consolidating its vaccine manufacturing operations to one site—located in Canada—amid the pharma’s recent $2.5 billion savings campaign.biospace · 14d ago
Data sources
last refreshed 2h ago
Found something off?
comments(0)
5-min edit window · permanent after that